DeSantis Misleads on Omicron-Resistant COVID-19 Antibody Treatments

After the Food and Drug Administration pulled its authorization of two COVID-19 antibody drugs because the treatments are highly unlikely to work against the omicron variant, Gov. Ron DeSantis of Florida misleadingly claimed the decision had been made “without a shred of clinical data” to support it. There may not be data from patients, but lab studies strongly suggest the treatments will not help omicron-infected people.

On Jan. 24, the FDA announced it was no longer authorizing two COVID-19 monoclonal antibody drugs in the U.S., given evidence that they are “highly unlikely”...